Compare NXAT & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXAT | IMCC |
|---|---|---|
| Founded | 2023 | 1980 |
| Country | Cayman Islands | Canada |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 1.0M |
| IPO Year | 2023 | 2019 |
| Metric | NXAT | IMCC |
|---|---|---|
| Price | $0.53 | $0.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 176.6K | 57.2K |
| Earning Date | 12-01-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $60.66 |
| Revenue Next Year | N/A | $6.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.09 |
| 52 Week High | $1.23 | $8.65 |
| Indicator | NXAT | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 31.93 |
| Support Level | $0.33 | $0.24 |
| Resistance Level | $1.15 | $0.55 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 59.35 | 23.08 |
Nexus Advanced Technologies Inc pursuing strategic investments, acquisitions, and partnerships across AI infrastructure and technologies. The Company's ideas include opportunities involving data centers, AI compute and GPU infrastructure, and other technologies supporting the development and deployment of artificial intelligence. Nexus seeks to combine access to capital, strategic partnerships, and technology opportunities to build a diversified platform positioned to participate in the continued growth of world-wide AI infrastructure.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.